Skip to main content

BRS3 — Inflammation & Oxidative Stress

BRS3-3-7 - Cytokine Network Modulation​

(Coordinating Immune Signalling Intensity)

1. Mission & Overview + Dietary Levers​

Mission​

Tune downstream cytokine signalling intensity so inflammatory tone does not remain chronically elevated.

No cited study establishes a preparation, supplement protocol, sleep practice, activity practice, or stress-recovery practice that changes this circulating cytokine step. Omega-3 capsules were tested in two attached trials. One did not change plasma IL-6, TNF-α, or CRP. The other lowered stimulated IL-6 production in student blood cells. Neither result is a practice for this circulating cytokine network.

Intervention Dominance: Not established — No principal intervention route established

Omega-3 capsules were tested in two attached trials. One did not change plasma IL-6, TNF-α, or CRP. The other lowered stimulated IL-6 production in student blood cells. Neither result is a practice for this circulating cytokine network, and neither is a sleep, activity, or stress-recovery lever. No route is ranked above another, because none is established.

Overview​

IL-6 and TNF-α are inflammatory messengers. Slavich and Irwin (2014) place them on the path from stress-related immune signalling to inflammatory tone. [5] Ferguson et al. (2014) used an endotoxin challenge in healthy adults to read that response. [2] EPA plus DHA did not significantly change IL-6 or TNF-α in that challenge. [2] CRP is a blood marker, not the messenger step.

  • Benefits: Tuning this intensity is about the messengers themselves, including IL-6 and TNF-α, after upstream genes have already been switched on. [5]
  • Implementation Notes: The new DHA admission is endpoint- and context-specific; the earlier null circulating-cytokine result remains relevant counterevidence. In the endotoxin trial, EPA plus DHA did not significantly change IL-6 or TNF-α. [2]
  • Biological Relevance: The transcriptional step that sits ahead of these messengers is separate — see PM1.

2. Primary Biological Effects​

↓ IL-6/TNF-a pressure; ↓ inflammatory signalling tone

3. Intervention Levers​

4. Mechanistic Basis​

Summary​

Inflammatory tone is expressed not only at transcriptional nodes but through circulating cytokine networks. This PM captures whether IL-6, TNF-α, and CRP-linked signalling remains elevated or moves toward resolution within BRS3(FM3) - Inflammation Resolution Capacity.

4.1 Scientific Findings (2)​

Summary​

IL-6 and TNF-α are messenger signals of inflammatory tone. CRP is a blood marker linked to that tone, not the messenger step. An endotoxin challenge in healthy adults has been used to read these responses. EPA plus DHA did not significantly change IL-6 or TNF-α in that challenge.

5. BRS Pathways and Connections​

5.1 BRS Pathways​

  • None listed

5.2 Cross-BRS Mechanism Relationships​

Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.

5.3 Local BRS Mechanism Relationships​

Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.

7. Phenome Connections​

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Focus / Attention Stability — modulatesOpen Page →
Cognitive Clarity — modulatesOpen Page →
Apprehensive Worry / Perseverative Thought — modulatesOpen Page →
Pleasure & Interest Capacity — modulatesOpen Page →

8. References​